- Home
- LPCN vs ADGM Comparison
LPCN vs ADGM Comparison
Compare LPCN & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- ADGM
- Stock Information
- Founded
- LPCN 1997
- ADGM 2011
- Country
- LPCN United States
- ADGM United States
- Employees
- LPCN N/A
- ADGM N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- ADGM
- Sector
- LPCN Health Care
- ADGM
- Exchange
- LPCN Nasdaq
- ADGM NYSE
- Market Cap
- LPCN 16.1M
- ADGM 14.7M
- IPO Year
- LPCN N/A
- ADGM N/A
- Fundamental
- Price
- LPCN $3.10
- ADGM $1.11
- Analyst Decision
- LPCN Strong Buy
- ADGM
- Analyst Count
- LPCN 1
- ADGM 0
- Target Price
- LPCN $10.00
- ADGM N/A
- AVG Volume (30 Days)
- LPCN 10.3K
- ADGM 6.0M
- Earning Date
- LPCN 05-08-2025
- ADGM 05-15-2025
- Dividend Yield
- LPCN N/A
- ADGM N/A
- EPS Growth
- LPCN N/A
- ADGM N/A
- EPS
- LPCN N/A
- ADGM N/A
- Revenue
- LPCN $11,198,144.00
- ADGM $602,000.00
- Revenue This Year
- LPCN N/A
- ADGM N/A
- Revenue Next Year
- LPCN N/A
- ADGM N/A
- P/E Ratio
- LPCN N/A
- ADGM N/A
- Revenue Growth
- LPCN N/A
- ADGM 100.67
- 52 Week Low
- LPCN $2.75
- ADGM $0.63
- 52 Week High
- LPCN $11.79
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- LPCN 46.56
- ADGM N/A
- Support Level
- LPCN $2.82
- ADGM N/A
- Resistance Level
- LPCN $3.27
- ADGM N/A
- Average True Range (ATR)
- LPCN 0.23
- ADGM 0.00
- MACD
- LPCN 0.01
- ADGM 0.00
- Stochastic Oscillator
- LPCN 58.92
- ADGM 0.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.